Pramod Reddy

Pramod Reddy

Auto-generated profile, based on publicly available information

Pramod Reddy

Centre for Multidisciplinary Research, Anurag University, Hyderabad, Telangana, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2024 in Seminars in Medical Writing and Education
Verified
Journal Article
Open access
PDF file
VAVarsha Agarwal
Varsha Agarwal
BPB Lakshmi Priyanka
B Lakshmi Priyanka
PRPramod Reddy
Pramod Reddy
ASAmritpal Sidhu
Amritpal Sidhu
SGSuhas Gupta Gupta
Suhas Gupta Gupta
PVPooja Varma
Pooja Varma
Artificial intelligence (AI) raises challenging ethical questions concerning patient safety, liberty, and trust as it is used increasingly in healthcare systems, particularly in regard to diagnostic and treatment choices. Big improvements in the quality of care would follow from considerably more accurate and efficient medical assessments and treatment plans made possible by AI-assisted systems. These developments, meantime, also bring challenges about transparency, accountability, and the danger of depending too much on automated systems. Especially when crucial judgements have to be taken, one should carefully consider the moral questions raised by artificial intelligence use in medical care. This is to guarantee that without violating ethical standards, these technologies enhance patient well-being. The moral issues raised by utilising artificial intelligence to support diagnostic and treatment decisions are investigated in this paper. It mostly addresses the discrepancy between human expertise and machine recommendations. Among the issues are the possibility of artificial bias, the clarity of AI decision-making procedures, and how AI will change the rapport between a doctor and a patient. The research also examines the need of patients continuing to trust automated medical systems as well as the possibility of dehumanising treatment when artificial intelligence systems take over decision-making duties. The paper also addresses the difficulty of ensuring that artificial intelligence systems abide by moral standards like promoting good, avoiding damage, and honouring patient liberty. With an eye on striking a balance between new technology and patient safety, the research also proposes guidelines and criteria for the appropriate use of artificial intelligence in healthcare. The interactions between ethical norms and artificial intelligence technology are examined in this paper. The aim is to provide a whole picture of how artificial intelligence might be employed in healthcare settings to raise patient outcomes while reducing risks and maintaining confidence by means of effective application.

29 August 2025 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
PMPragati Aniket Manoli
Pragati Aniket Manoli
RGRashmi Gudur
Rashmi Gudur
JKJatin Khurana
Jatin Khurana
ASAakash Sharma
Aakash Sharma
PRPramod Reddy
Pramod Reddy
SPSoumya Surath Panda
Soumya Surath Panda
Cancer is still one of the main reasons of death in the world, and treating cancers in their later stages is very hard. Chemotherapy and immunotherapy are the two main ways to treat advanced cancer. They work in different ways and have different benefits and drawbacks. This essay looks at chemotherapy and immunotherapy side by side, comparing how well they work, how safe they are, and how they affect patient results when treating advanced cancers. Chemotherapy is a common treatment that targets cancer cells that divide quickly. This shrinks the growth and stops the disease from getting worse. While chemotherapy has been shown to help some types of cancer, it often comes with serious side effects like weakened immune systems, stomach problems, and hair loss that can make patients' quality of life very bad. Immunotherapy, on the other hand, uses the immune system to find cancer cells and kill them. Immunotherapy, on the other hand, can cause long-lasting recovery by activating immune reactions that target cancer cells, and in some cases, it has fewer side effects. Several methods are used in this method, including immune checkpoint inhibitors, monoclonal antibodies, and cancer medicines. Immunotherapy has shown promise in treating cancers that didn't respond to treatment before, like melanoma, lung cancer, and some types of lymphoma. On the other hand, immunotherapy can cause immune-related side effects like swelling in good organs, which could lead to major problems. This review looks at the most important studies and clinical trials that have compared how well and safely chemotherapy and immunotherapy treat advanced cancer. We look at the rates of reaction, total survival, progression-free survival, and unfavorable events that happen with these different types of treatment. The study also talks about the things that affect the choice of treatment, such as the type of cancer, the patient's health, and their previous treatment history.

9 August 2025 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
MAMónica Alexandra Caiza Asitimbay
Mónica Alexandra Caiza Asitimbay
TKTarun Kapoor
Tarun Kapoor
RMRamish Maqsood
Ramish Maqsood
PRPramod Reddy
Pramod Reddy
LSLulup Kumar Sahoo
Lulup Kumar Sahoo
PAPrateek Aggarwal
Prateek Aggarwal
The consequences of cannabis usage on Multiple Sclerosis (MS) and Parkinson's disease (PD) are still substantially uncertain despite recognizing that Cannabis was used for thousands of years as a medication. The evaluation of cannabis usage PD and MS, and a comparison of cannabis users' and non-users' self-reported assessments of neurological impairment were primary goals of this research. The survey contained standardized questions to collect information on demographics and Cannabis use questionnaires to evaluate participants' physical activity levels, neurological function, and weariness. Linear regression, Hierarchical Regression, and ANCOVA analysis of variance were employed in research. Were 900 respondents in a final data set. Cannabis consumers today were younger and less inclined to be considered fat. Regarding Emotional Variability, Cognitive Function, and Fatigue, cannabis users reported decreased degrees of disability. Cannabis may benefit PD and MS patients' Emotional Variability, Cognitive Function, Fatigue, and Physiological Weight. PD and MS patients' cannabis use: long-term advantages and downsides, and determining if these relationships are causal, more research is required to utilize longitudinally and clinically measured assessments among these domains.